A STUDY TO INVESTIGATE EFFICACY AND SAFETY OF COBIMETINIB PLUS ATEZOLIZUMAB AND ATEZOLIZUMAB MONOTHERAPY VERSUS REGORAFENIB IN PARTICIPANTS WITH METASTATIC COLORECTAL ADENOCARCINOMA (COTEZO IMBLAZE370):